Breaking News, Collaborations & Alliances

Almac Participates in Global Clinical Supply BlockChain Working Group

Project spearheaded by Biogen and Pfizer explores how technology can address the growing demands of clinical trials

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Almac Group, the global pharmaceutical contract development and manufacturing organization (CDMO), is participating in the Global Clinical Supply BlockChain working group (GCSBWG).   Given how well-suited the BlockChain technology is for supply chains where numerous organizations must handle sensitive information, the multi-stakeholder group, spearheaded by Biogen and Pfizer, convened to explore whether technology could address the growing demands of clinical trials.   With Phase 1 of the GSCWG ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters